Anthony Giordano
President and CEO @Neurotherapia, Inc
Cleveland, OH, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Dec 2019 — Present
President and CEO @Neurotherapia, Inc
View department →
NeuroTherapia is developing CB2 agonists for treatment of neurodegenerative diseases. Tony has oversaw the development of the company, including its recent Phase 1a and 1b clinical trials and development of 2nd generation molecules.
SKILLS
Business StrategyGeneticsDrug DiscoveryBiopharmaceuticalsLife SciencesImmunologyClinical DevelopmentEntrepreneurshipPharmaceutical IndustryCell BiologyBiotechnologyMedical DevicesProduct DevelopmentDrug DevelopmentBioinformaticsCommercializationBiochemistryMolecular BiologyStart-UpsLifesciencesTranslational ResearchBusiness DevelopmentPharmacologyCell CultureTechnology TransferStrategic Planning
ABOUT ANTHONY GIORDANO
Experienced Chief Executive Officer with a demonstrated history of working in the…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.